| Authors | Title | Published | Journal | PubMed Link |
|---|---|---|---|---|
| Kardos P | [Chronic persistent cough]. | 1995 | Pneumologie | pmid:7892152 |
| Sivasundram A | A case of monilethrix treated with etretinate. | 1995 | Dermatology (Basel) | pmid:7894110 |
| Eisenhardt EU and Bickel MH | Kinetics of tissue distribution and elimination of retinoid drugs in the rat. II. Etretinate. | 1994 Jan-Feb | Drug Metab. Dispos. | pmid:8149886 |
| Chaffai M et al. | [Keratoacanthoma centrifugum marginatum]. | 1994 | Ann Dermatol Venereol | pmid:7793766 |
| Torii H et al. | Interferon-alpha (INF-alpha) and etretinate in the treatment of mycosis fungoides. | 1994 | J. Dermatol. | pmid:7798436 |
| Bolla M et al. | Prevention of second primary tumours with etretinate in squamous cell carcinoma of the oral cavity and oropharynx. Results of a multicentric double-blind randomised study. | 1994 | Eur. J. Cancer | pmid:7917535 |
| Osada K et al. | Etretinate administration reduces serum propeptide of type I procollagen level in patients with psoriasis. | 1994 | Br. J. Dermatol. | pmid:7999596 |
| el-Sherif AI et al. | Leukocyte-extracellular matrix interactions in psoriasis. | 1994 | Int. J. Dermatol. | pmid:8039977 |
| Okada N et al. | Bone mineral density of the lumbar spine in psoriatic patients with long term etretinate therapy. | 1994 | J. Dermatol. | pmid:8051315 |
| Akovbyan VA et al. | Successful treatment of acanthosis nigricans with etretinate. | 1994 | J. Am. Acad. Dermatol. | pmid:8021356 |
| Kano Y et al. | Cholestatic hepatitis occurring shortly after etretinate therapy. | 1994 | J. Am. Acad. Dermatol. | pmid:8021361 |
| Mesrobian HG et al. | Cloacal and urogenital abnormalities induced by etretinate in mice. | 1994 | J. Urol. | pmid:8021993 |
| Laugier JP et al. | Acitretin biotransformation into etretinate: role of ethanol on in vitro hepatic metabolism. | 1994 | Dermatology (Basel) | pmid:8136538 |
| Hirokawa M et al. | Confluent and reticulated papillomatosis: a case with concurrent acanthosis nigricans associated with obesity and insulin resistance. | 1994 | Dermatology (Basel) | pmid:8136544 |
| Nanda A and Alsaleh QA | Hair discoloration caused by etretinate. | 1994 | Dermatology (Basel) | pmid:8136552 |
| Schulze-Dirks A | [Epicutaneous tests in etretinate therapy]. | 1994 | Hautarzt | pmid:8071075 |
| Takizawa S et al. | Effect of etretinate (aromatic retinoid) treatment during gestation and lactation periods on viability and somatic growth in F1 rats. | 1994 | J Toxicol Sci | pmid:8072039 |
| Frati C et al. | Association of etretinate and fish oil in psoriasis therapy. Inhibition of hypertriglyceridemia resulting from retinoid therapy after fish oil supplementation. | 1994 | Acta Derm Venereol Suppl (Stockh) | pmid:8073820 |
| Geiger JM et al. | Teratogenic risk with etretinate and acitretin treatment. | 1994 | Dermatology (Basel) | pmid:8075435 |
| Glover MT et al. | Non-melanoma skin cancer in renal transplant recipients: the extent of the problem and a strategy for management. | 1994 | Br J Plast Surg | pmid:8149064 |
| Kremer I et al. | Toxic effects of systemic retinoids on meibomian glands. | 1994 | Ophthalmic Res. | pmid:8196934 |
| Bayle-Lebey P et al. | [Cutaneous carcinoma and papillomavirus 5. Discovered during prolonged UVA photochemotherapy]. | 1994 | Ann Dermatol Venereol | pmid:7702285 |
| Lippman SM et al. | Retinoid chemoprevention studies in upper aerodigestive tract and lung carcinogenesis. | 1994 | Cancer Res. | pmid:8137332 |
| Fölster-Holst R and Christophers E | [Filiform keratosis]. | 1994 | Hautarzt | pmid:7928345 |
| Wong SS and Marks R | Cutaneous vasculitis in psoriasis. | 1994 | Acta Derm. Venereol. | pmid:7908486 |
| Zhang JZ et al. | Effects of etretinate on keratinocyte proliferation and secretion of interleukin-1 alpha (IL-1 alpha) and IL-8. | 1994 | J. Dermatol. | pmid:7962965 |
| Sturkenboom MC et al. | Inability to detect plasma etretinate and acitretin is a poor predictor of the absence of these teratogens in tissue after stopping acitretin treatment. | 1994 | Br J Clin Pharmacol | pmid:7826824 |
| Arnold A et al. | The arotinoids: early clinical experience and discussion of future development. | 1994 | Leukemia | pmid:7808024 |
| Fernández-Redondo V et al. | Sarcoid-like granuloma following prolonged etretinate treatment. | 1994 | Dermatology (Basel) | pmid:8186514 |
| de Misa RF et al. | Psoriatic arthritis: one year of treatment with extracorporeal photochemotherapy. | 1994 | J. Am. Acad. Dermatol. | pmid:8188874 |
| Zemtsov A et al. | Human in vivo phosphorus 31 magnetic resonance spectroscopy of psoriasis. A noninvasive tool to monitor response to treatment and to study pathophysiology of the disease. | 1994 | J. Am. Acad. Dermatol. | pmid:8188887 |
| Prasad RS et al. | Management and follow-up of harlequin siblings. | 1994 | Br. J. Dermatol. | pmid:8204475 |
| von den Driesch P et al. | ["Granulomatous slack skin"--cutaneous elastolytic lymphoma]. | 1994 | Hautarzt | pmid:7843967 |
| Dicken CH | Treatment of classic pityriasis rubra pilaris. | 1994 | J. Am. Acad. Dermatol. | pmid:7962784 |
| Watts P et al. | Localization of transforming growth factor-alpha RNA and protein in the skin of psoriatic patients receiving therapy. | 1994 | Br. J. Dermatol. | pmid:7519033 |
| Brechtel B et al. | Combination of etretinate with cyclosporine in the treatment of severe recalcitrant psoriasis. | 1994 | J. Am. Acad. Dermatol. | pmid:8188867 |
| Inoue K et al. | Etretinate-induced heterotopic bone formation about the hip joint. A case report including ultrastructural study. | 1994 | Clin. Orthop. Relat. Res. | pmid:7955675 |
| Meyer E et al. | Skin, adipose tissue and plasma levels of acitretin with rare occurrence of esterified acitretin during long-term treatment. | 1993 | Acta Derm. Venereol. | pmid:8103254 |
| Hesse S et al. | Psoriasis and birdshot chorioretinopathy: response to aromatic retinoids. | 1993 | Dermatology (Basel) | pmid:8358104 |
| Geiger JM and Saurat JH | Acitretin and etretinate. How and when they should be used. | 1993 | Dermatol Clin | pmid:8435906 |
| Altomare GF et al. | Intramuscular low dose alpha-2B interferon and etretinate for treatment of mycosis fungoides. | 1993 | Int. J. Dermatol. | pmid:8440560 |
| Hausser I et al. | [Olmsted syndrome. Successful therapy by treatment with etretinate]. | 1993 | Hautarzt | pmid:8335464 |
| Kiricuta IC et al. | Altered muscle metabolism in pustular psoriasis (Zumbusch type): demonstration by 31P magnetic resonance spectroscopy. | 1993 | Dermatology (Basel) | pmid:8453141 |
| Bergman R et al. | Mal de Meleda keratoderma with pseudoainhum. | 1993 | Br. J. Dermatol. | pmid:8457455 |
| Furukawa F et al. | [Pustular psoriasis and psoriasis vulgaris]. | 1993 | Nippon Rinsho | pmid:8459635 |
| Patrizi A et al. | Lamellar ichthyosis with laminated membrane structures. | 1993 | Br. J. Dermatol. | pmid:8471522 |
| Dreno B et al. | Roferon-A in combination with Tigason in cutaneous T-cell lymphomas. | 1993 | Acta Haematol. | pmid:8475670 |
| Theiler R et al. | [Diffuse idiopathic skeletal hyperostosis (DISH) and pseudo-coxarthritis following long-term etretinate therapy]. | 1993 | Schweiz Med Wochenschr | pmid:8480163 |
| Judge MR et al. | Pustular psoriasis in childhood. | 1993 | Clin. Exp. Dermatol. | pmid:8482007 |
| Verweij J and Stoter G | [Vitamin A derivatives: potential prevention and therapy of solid tumors]. | 1993 | Ned Tijdschr Geneeskd | pmid:8487881 |
Etretinate
Etretinate is a lipid of Prenol Lipids (PR) class. Etretinate is associated with abnormalities such as Psoriasis, Skin lesion, Scleroderma, Chronic graft-versus-host disease and Evaluable Disease. The involved functions are known as Agent, Ulcer and Teratogenesis. Etretinate often locates in Hepatic and Skin. The related lipids are Steroids and Steroid, Systemic.
Cross Reference
Introduction
To understand associated biological information of Etretinate, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.
What diseases are associated with Etretinate?
Etretinate is suspected in Scleroderma, Chronic graft-versus-host disease, Psoriasis, Skin lesion, Evaluable Disease, Pneumonia, Bacterial and other diseases in descending order of the highest number of associated sentences.
Related references are mostly published in these journals:
| Disease | Cross reference | Weighted score | Related literature |
|---|
Loading... please refresh the page if content is not showing up.
No disease MeSH terms mapped to the current reference collection.
PubChem Associated disorders and diseases
What pathways are associated with Etretinate
There are no associated biomedical information in the current reference collection.
PubChem Biomolecular Interactions and Pathways
Link to PubChem Biomolecular Interactions and PathwaysWhat cellular locations are associated with Etretinate?
Visualization in cellular structure
Associated locations are in red color. Not associated locations are in black.
Related references are published most in these journals:
| Location | Cross reference | Weighted score | Related literatures |
|---|
Loading... please refresh the page if content is not showing up.
What functions are associated with Etretinate?
Related references are published most in these journals:
| Function | Cross reference | Weighted score | Related literatures |
|---|
What lipids are associated with Etretinate?
Related references are published most in these journals:
| Lipid concept | Cross reference | Weighted score | Related literatures |
|---|
Loading... please refresh the page if content is not showing up.
What genes are associated with Etretinate?
There are no associated biomedical information in the current reference collection.
What common seen animal models are associated with Etretinate?
There are no associated biomedical information in the current reference collection.